Loading
Latest filing published 18 Jun 2026 for GENELUX CORP.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Eric Groen is a declared insider at 2 companies (board member); the most frequent names are Rani Therapeutics Holdings, Inc. and Genelux Corp. We count 4 filings; the first trade dates from 22 March 2022 and the latest from 16 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 18 June 2026, reports a share grant in Genelux Corp. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations